BlogOut

BlogOut provides regular, global outsourcing updates. See BlogOut Directory for the complete list of categories

See also outsourcing updates for related categories: Medicine & Healthcare, India

Indian Pharma Companies for Inorganic Route to Billion-dollar Club

Tinesh Bhasin, DNA India

MUMBAI: Indian pharma firms are now eyeing inorganic growth overseas as they inch towards the elite billion dollar club. They see acquisitions contributing 20-40% of revenues, in the process assisting them to to breach the billion dollar mark.

Companies such as Lupin are looking for a distribution company is US, and aims to achieve $1 billion in sales in two years. This target is difficult to achieve without any acquisitions.

Four many more domestic pharmaceutical companies, including Nicholas Piramal, Cadila, Aurobindo and Wockhardt, too, are marching towards the billion dollar club. Analysts feel that though achievable, these companies need acquisitions to breach that mark, says this report @ DNA India

Click on the labels below for more posts on those categories

Labels: acquisitions-pharma, competitive-advantage, pharma-india

Pharma ChemOutsourcing Show to Gather Pharma, Biotech, and CROs at Industry Conference on September 10-11 in New Jersey

12 Mar 2007

NEW BRUNSWICK, N.J. - The worldwide Pharma, Biotech, Emerging pharma, and supplier chemistry sourcing industries will gather on September 10-11 in the United States to attend Pharma ChemOutsourcing, an annual show bringing together purchasers and suppliers of chemical services exclusively for the pharmaceutical industry.

Focus will center around cutting-edge conferences and expositions on chemistry outsourcing from early discovery through clinical drug development and drug substance. Panel discussion topics include sourcing custom synthesis, discovery, advanced intermediates, APIs, material management, drug substance, major geo-regions such as India, China, Europe, USA...

Read the full report from here @ PR Inside

BlogOut provides global outsourcing updates across industries & business functions. See BlogOut Directory for the complete list of categories

Labels: chemicals, chemicals-usa, events, events-pharma, pharma, pharma-china, pharma-india, pharma-trends, pharma-usa

India Striving to Become A Pharmaceutical Outsourcing Hub

Talking about the future of Indian companies operating in the field of contract research and manufacturing, an Indian pharma CEO said the attempts made by Indian pharma firms to make more value across the drug discovery and development chain will result in these firms with critical mass and scale. He also said that many large Indian players who used to deal in generics-only have started to develop their own R&D programs and several of these will certainly diversify their operation to offer discovering services on contract basis also as experience, skills and capacity rise.

Read the full report from here @ India Stock Market

BlogOut provides global outsourcing updates across industries & business functions. See BlogOut Directory for the complete list of categories

Labels: pharma, pharma-asia, pharma-india, pharma-trends

Novartis forms BPO pact with Genpact

08 Feb 2007

Swiss giant drugmaker Novartis has signed a contract deal with services provider Genpact to outsource some of its business processes to India.

India-based Genpact will provide the pharma division of Novartis with support in accounting and purchasing activities and manage this as a global shared service, Chris Lewis.

More from this Bio-pharma Reporter article

BlogOut provides regular, global outsourcing updates for all industries & business functions, in hundreds of categories. See BlogOut Directory for the complete list of categories

Labels: accounting-india, accounting-pharma, accounting-switzerland, pharma, pharma-europe, pharma-india, pharma-switzerland, purchasing, purchasing-pharma, switzerland

Granules India signs outsourcing deal with Australian firm

Hyderabad, March 5, 2007 (PTI): Pharmceuticals company Granules India Ltd today said it has entered into an outsourcing agreement with Australia's Matchland Pty Ltd to manufacture drugs for the latter for the Australian market. This would be Matchland's first outsourcing agreement with any Indian company...

Real the full report from The Hindu

BlogOut provides regular, global outsourcing updates for all industries & business functions, in hundreds of categories. See BlogOut Directory for the complete list of categories

Labels: pharma, pharma-asia, pharma-australia, pharma-india

Actavis gains new contract manufacturing capabilities in India

By Kirsty Barnes

15 February 2007

Actavis has waded further into India and picked up new contract manufacturing capabilities along the way with the purchase of a division of Sanmar Specialty Chemicals (SSCL).

The acquired active pharmaceutical ingredients (API) division mainly conducts API contract manufacturing for both the Indian and international pharmaceutical markets.

Read more from this in Pharma Technologist report

Labels: acquisitions, acquisitions-pharma, active-pharmaceutical-ingredients, contract-manufacturing, contract-manufacturing-india, contract-manufacturing-pharma, pharma, pharma-india